CH454160A - Procédé de préparation de nouveaux dérivés du spiro-(4,5)-décane - Google Patents

Procédé de préparation de nouveaux dérivés du spiro-(4,5)-décane

Info

Publication number
CH454160A
CH454160A CH558965A CH558965A CH454160A CH 454160 A CH454160 A CH 454160A CH 558965 A CH558965 A CH 558965A CH 558965 A CH558965 A CH 558965A CH 454160 A CH454160 A CH 454160A
Authority
CH
Switzerland
Prior art keywords
preparation
decane derivatives
novel spiro
spiro
novel
Prior art date
Application number
CH558965A
Other languages
English (en)
French (fr)
Inventor
Regnier Gilbert
Canevari Roger
Claude Le Douarec Jean
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of CH454160A publication Critical patent/CH454160A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
CH558965A 1964-04-22 1965-04-22 Procédé de préparation de nouveaux dérivés du spiro-(4,5)-décane CH454160A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16696/64A GB1100281A (en) 1964-04-22 1964-04-22 New spiro-decane derivatives and process for the preparation thereof

Publications (1)

Publication Number Publication Date
CH454160A true CH454160A (fr) 1968-04-15

Family

ID=10081982

Family Applications (1)

Application Number Title Priority Date Filing Date
CH558965A CH454160A (fr) 1964-04-22 1965-04-22 Procédé de préparation de nouveaux dérivés du spiro-(4,5)-décane

Country Status (9)

Country Link
US (1) US3399192A (US07235543-20070626-C00026.png)
BE (1) BE662817A (US07235543-20070626-C00026.png)
CH (1) CH454160A (US07235543-20070626-C00026.png)
DE (1) DE1620262C3 (US07235543-20070626-C00026.png)
ES (2) ES312091A1 (US07235543-20070626-C00026.png)
FR (2) FR1441575A (US07235543-20070626-C00026.png)
GB (1) GB1100281A (US07235543-20070626-C00026.png)
NL (2) NL6504602A (US07235543-20070626-C00026.png)
SE (1) SE307793B (US07235543-20070626-C00026.png)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129025C (US07235543-20070626-C00026.png) * 1965-04-29
US3542729A (en) * 1968-03-19 1970-11-24 Sankyo Co Stabilization of synthetic polymers
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
US4244961A (en) * 1978-10-26 1981-01-13 Syntex (U.S.A.) Inc. 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents
US4255432A (en) * 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
ES517622A0 (es) * 1982-11-23 1983-12-16 Faes Procedimiento de preparacion de un nuevo espirodecano.
HU204054B (en) * 1989-08-10 1991-11-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
FR2666583B1 (fr) * 1990-09-06 1994-09-09 Adir Nouveaux derives du spiro [4.5] decane, leur procede de preparation et leurs compositions pharmaceutiques les renfermant.
FR2734265B1 (fr) * 1995-05-17 1997-06-13 Adir Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
PT1353694E (pt) * 2001-01-26 2008-03-12 Schering Corp Combinações de ezetimiba com aspirina para o tratamento de doenças vasculares
MXPA03006727A (es) * 2001-01-26 2003-10-24 Schering Corp Combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y tratamiento para indicaciones vasculares.
DE60221798T2 (de) * 2001-01-26 2008-06-05 Schering Corp. Kombinationen von gallensäure sequestriermitteln und hemmern der sterol absorption zur behandlung von kardiovaskulären indikationen
ES2286233T3 (es) * 2001-01-26 2007-12-01 Schering Corporation Combinaciones de inhibidor(es) de la absorcion de esteroles con agente(s) cardiovascular(es) para el tratamiento de afecciones vasculares.
RU2756946C2 (ru) * 2001-01-26 2021-10-07 Мерк Шарп И Доум Корп. Применение замещенных азетидинонов для лечения ситостеролемии
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DK1353696T3 (da) * 2001-01-26 2007-04-10 Schering Corp Kombinationer af peroxisomproliferatoraktiveret receptor (PPAR)-aktivator(er) og sterolabsorptionsinhibitor(er) og behandlinger til vaskulære indikationer
CA2447884A1 (en) * 2001-05-25 2002-12-05 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
DE10130020A1 (de) * 2001-06-25 2003-12-04 Gruenenthal Gmbh Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
EP1429756B1 (en) * 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
PT1427409E (pt) * 2001-09-21 2008-11-27 Schering Corp Métodos para tratar ou para impedir a inflamação vascular utilizando inibidor(es) de absorção de esteróis
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
WO2004043456A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
CA2517573C (en) * 2003-03-07 2011-12-06 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
EP1601668B1 (en) 2003-03-07 2008-08-27 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ES2318274T3 (es) 2003-03-07 2009-05-01 Schering Corporation Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
CA2544309A1 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
RU2006132465A (ru) * 2004-02-10 2008-03-20 Ф.Хоффманн-Ля Рош Аг (Ch) Модуляторы хемокинового рецептора ccr5
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
MX2009010503A (es) * 2007-03-29 2009-10-19 Hoffmann La Roche Compuestos heterociclicos antiviricos.
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN102766147B (zh) * 2012-08-03 2015-07-15 无锡药兴医药科技有限公司 一种芬司匹利及其氢卤酸盐的制备方法
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437388A (en) * 1948-03-09 Z-oxazolidone compounds and proc
US3193559A (en) * 1965-07-06 New derivatives of z-oxazolidinones
US2500714A (en) * 1944-10-30 1950-03-14 Abbott Lab 4-phenyl-1-alkyl isonipecotic acid lactones
US3054794A (en) * 1958-01-17 1962-09-18 Us Vitamin Pharm Corp Process for preparing 3-(aminoalkyl)-oxazolidine-2, 4-diones
GB974134A (en) * 1963-03-28 1964-11-04 Science Union Et Compagnie Soc Oxazolidinone derivatives

Also Published As

Publication number Publication date
FR4463M (US07235543-20070626-C00026.png) 1966-09-26
ES361975A2 (es) 1971-01-16
NL127065C (US07235543-20070626-C00026.png)
GB1100281A (en) 1968-01-24
SE307793B (US07235543-20070626-C00026.png) 1969-01-20
DE1620262B2 (de) 1979-10-11
DE1620262C3 (de) 1980-07-03
BE662817A (US07235543-20070626-C00026.png) 1965-10-21
US3399192A (en) 1968-08-27
FR1441575A (fr) 1966-06-10
ES312091A1 (es) 1965-10-01
NL6504602A (US07235543-20070626-C00026.png) 1965-10-25
DE1620262A1 (de) 1972-03-23

Similar Documents

Publication Publication Date Title
CH454160A (fr) Procédé de préparation de nouveaux dérivés du spiro-(4,5)-décane
CH436269A (fr) Procédé de préparation de nouveaux dérivés du dibenzocycloheptatriène
CH464943A (fr) Procédé pour la préparation de nouveaux dérivés de 1-amino-fluorenone
CH429713A (fr) Procédé de préparation de nouveaux dérivés gonatriéniques
FR94101E (fr) Procédé de préparation de nouveaux dérivés de benzoxazépine.
CH470393A (fr) Procédé de préparation de dérivés de la berbine
CH469010A (fr) Procédé de préparation de dérivés du diazabicyclo-(4,4,0)-décane
CH463511A (fr) Procédé de préparation de nouveaux dérivés du pipérazino-phényléthanol
CH425753A (fr) Procédé de préparation de dérivés substitués du 1,3-dioxo-cyclopentane
OA01087A (fr) Procédé de préparation de nouveaux dérivés de benzamidobenzanilide
CH439276A (fr) Procédé de préparation de nouveaux dérivés du dibenzocycloheptadiène
CH459227A (fr) Procédé de préparation de nouveaux dérivés du dibenzocycloheptatriène
CH478149A (fr) Procédé de préparation de nouveaux dérivés de dialcoylcystéines
FR1458956A (fr) Procédé de préparation de nouveaux dérivés d'hydrazine
CH463505A (fr) Procédé de préparation de nouveaux dérivés du dibenzocycloheptadiène
CH492707A (fr) Procédé de préparation de nouveaux dérivés du dibenzocycloheptatriène
CH451963A (fr) Procédé de préparation de dérivés benzofuranniques
CH449022A (fr) Procédé de préparation de dérivés du 3-azabicyclo (3,2,2,)nonane
CH426788A (fr) Procédé de préparation de nouveaux dérivés du dibenzocycloheptadiène
CH454867A (fr) Procédé de préparation de nouveaux dérivés de la phénothiazine
CH472413A (fr) Procédé de préparation de nouveaux dérivés du dibenzocycloheptadiène
CH430748A (fr) Procédé de préparation de nouveaux dérivés benzofuranniques
CH435277A (fr) Procédé de préparation de dérivés du 2-phényl-acrylate de 3-tropanyle
CH473814A (fr) Procédé de préparation des nouveaux dérivés du diaza-1,4-bicyclo-(4,4,0)-benzo-(1,2,h)-décane
FR1490462A (fr) Procédé de préparation de nouveaux dérivés de cinnamanilides